VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab | Zendy

Markus Moehler | Zendy; Christian Frings | Zendy; Annett Mueller | Zendy; Ines Gockel | Zendy; Carl C. Schimanski | Zendy; Stefan Biesterfeld | Zendy; Peter R. Galle | Zendy; Martin Holtmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab

Author(s) -

Markus Moehler,

Christian Frings,

Annett Mueller,

Ines Gockel,

Carl C. Schimanski,

Stefan Biesterfeld,

Peter R. Galle,

Martin Holtmann

Publication year - 2008

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.14.4156

Subject(s) - cetuximab , colorectal cancer , epidermal growth factor receptor , medicine , cancer research , immunohistochemistry , vascular endothelial growth factor , lymph node , lymphangiogenesis , receptor , cancer , oncology , pathology , vegf receptors , metastasis

To gain mechanistic insights into the role played by epidermal growth factor receptor (EGFR) in the regulation of vascular endothelial growth factors (VEGFs) in colorectal cancer (CRC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research